Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jupiter Neurosciences (JUNS) Change in Accured Expenses (2024 - 2025)

Jupiter Neurosciences (JUNS) has disclosed Change in Accured Expenses for 2 consecutive years, with -$395194.0 as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses fell 47.97% to -$395194.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $38765.0 through Dec 2025, up 125.92% year-over-year, with the annual reading at $38765.0 for FY2025, 125.92% up from the prior year.
  • Change in Accured Expenses for Q4 2025 was -$395194.0 at Jupiter Neurosciences, down from -$8867.0 in the prior quarter.
  • The five-year high for Change in Accured Expenses was $556378.0 in Q2 2025, with the low at -$395194.0 in Q4 2025.